Dermal Fillers and COVID-19: Angioedema With Urticaria in a Patient Post COVID-19 Infection.

Cureus

Dermatology, Academy of Aesthetic Medicine, Sheffield, GBR.

Published: April 2022

Hyaluronic acid dermal fillers are a very popular choice for patients wanting to undergo non-invasive facial rejuvenation. Its prevalence is predicted to continue to rise. We report a case of delayed angioedema and associated urticaria to hyaluronic acid dermal fillers post COVID-19 infection. To our knowledge, this is an unusual case of hypersensitivity reaction of eight-month latency. Although the aetiology warrants further research, the author suggests utilisation of a four-week time window between dermal filler injections and COVID-19 vaccination.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131708PMC
http://dx.doi.org/10.7759/cureus.24461DOI Listing

Publication Analysis

Top Keywords

dermal fillers
12
post covid-19
8
covid-19 infection
8
hyaluronic acid
8
acid dermal
8
dermal
4
covid-19
4
fillers covid-19
4
covid-19 angioedema
4
angioedema urticaria
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!